Immunologic reduction of bladder cancer recurrence rate.
D000328:Adult; D000368:Aged; D000956:Antigens, Viral / Q000008:administration & dosage; D002295:Carcinoma, Transitional Cell / Q000276:immunology*; D005260:Female; D006433:Hemocyanins / Q000008:administration & dosage; D006801:Humans; D006968:Hypersensitivity, Delayed; D007114:Immunization; D007271:Injections, Intradermal; D008297:Male; D008875:Middle Aged; D009109:Mumps virus / Q000276:immunology; D009364:Neoplasm Recurrence, Local; D012882:Skin Tests; D013299:Streptodornase and Streptokinase / Q000008:administration & dosage; D014374:Tuberculin Test; D001749:Urinary Bladder Neoplasms / Q000276:immunology*
D000956:Antigens, Viral; D006433:Hemocyanins; D013299:Streptodornase and Streptokinase